Abstract:NAD(P)H:quinone oxidoreductase 1 (NQO1) has been shown to be a potential therapeutic target for various human diseases, such as cancer and neurodegenerative disorders. Recent advances in computational methods, especially network-based methods, have made it possible to identify novel compounds for a target with high efficiency and low cost. In this study, we designed a workflow combining network-based methods and identification of privileged substructures to discover new compounds targeting NQO1 from a natural product library. According to the prediction results, we purchased 56 compounds for experimental validation. Without the assistance of privileged substructures, 31 compounds (31/56 = 55.4%) showed IC<sub>50</sub> < 100 μM, and 11 compounds (11/56 = 19.6%) showed IC<sub>50</sub> < 10 μM. With the assistance of privileged substructures, the two success rates were increased to 61.8 and 26.5%, respectively. Seven natural products further showed inhibitory activity on NQO1 at the cellular level, which may serve as lead compounds for further development. Moreover, network analysis revealed that osthole may exert anticancer effects against multiple cancer types by inhibiting not only carbonic anhydrases IX and XII but also NQO1. Our workflow and computational methods can be easily applied in other targets and become useful tools in drug discovery and development.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00260?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00260</a>.Detailed information of the drugs used for network construction; detailed information of the targets used for network construction; detailed information of the DTIs used for network construction; statistics of the drug–substructure associations used for model construction; optimized parameters of global bSDTNBI models; evaluation indicators of our network-based models in 10-fold cross validation; target proteins predicted to 4027 compounds by the best model Global-bSDTNBI-FCFP_4; detailed information of the 86 compounds predicted to target NQO1 by the best model Global-bSDTNBI-FCFP_4; including the 56 compounds purchased for experimental validation; and ADMET properties predicted to the seven newly discovered NQO1 inhibitors (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00260/suppl_file/ci1c00260_si_001.xlsx">XLSX</a>)This article has not yet been cited by other publications.

Exploring of drug leads from diversity-oriented Michael-acceptor library derived from natural products

Ononin, Sec-O-β-d-glucosylhamaudol and Astragaloside I: Antiviral Lead Compounds Identified Via High Throughput Screening and Biological Validation from Traditional Chinese Medicine Zhongjing Formulary.

Mining Medicinally Relevant Bioreduction Substrates Inspired by Ligand-Based Drug Design

Use of Natural Products As Chemical Library for Drug Discovery and Network Pharmacology

Privileged Biorenewable Secologanin-Based Diversity-Oriented Synthesis for Pseudo-Natural Alkaloids: Uncovering Novel Neuroprotective and Antimalarial Frameworks

Integrated Approaches for Discovering Novel Drugs From Microbial Natural Products

Diversity-Oriented Synthesis of Natural-Product-like Libraries Containing a 3-Methylbenzofuran Moiety for the Discovery of New Chemical Elicitors.

Integration of Multiple Analytical and Computational Tools for the Discovery of High-Potency Enzyme Inhibitors from Herbal Medicines.

The discovery of oxazolones-grafted spirooxindoles via three-component diversity oriented synthesis and their preliminary biological evaluation

Thiol-trapping natural products under the lens of the cysteamine assay: friends, foes, or simply alternatively reversible ligands?

Discovery of Novel Tricyclic Thiazepine Derivatives As Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach

Focused Combinatorial Library Design Based on Structural Diversity, Druglikeness and Binding Affinity Score.

Lead/Drug Discovery from Natural Resources

Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael–aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity

Efficient Ligand Discovery from Natural Herbs by Integrating Virtual Screening, Affinity Mass Spectrometry and Targeted Metabolomics

Increasing the Odds of Drug Hit Identification by Screening Against Receptor Homologs?

Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors

Rapid identification of dual p53-MDM2/MDMX interaction inhibitors through virtual screening and hit-based substructure search

Design, Synthesis and Antitumor Research of Aza-Peptide Michael Acceptors

Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures

Total Synthesis and Biological Evaluation of Largazole and Derivatives with Promising Selectivity for Cancers Cells.